Skyline, Helomics, GLG partner for ovarian and breast cancer

GLG Pharma LLC (Jupiter, Fla.), Skyline Medical Inc. (NASDAQ:SKLN) and Helomics Corp. (Pittsburgh, Pa.) partnered to develop therapeutics and diagnostics for ovarian and breast cancer patients, especially those who present with ascites fluid. The companies intend to share revenue derived from products resulting from the partnership.

Skyline will use its Streamway system to collect ascites fluids identified by GLG's Cell Capture, Culture and Screening system. Helomics will process the samples using its ChemoFx diagnostic platform. ChemoFx is a marketed, ex vivo assay that uses a core biopsy to predict sensitivity and resistance of a patient's solid tumor to various chemotherapeutic agents...